Today's Daily Dose brings you news about stock offering of Assembly Biosciences, AcelRx Pharmaceuticals and Myovant Sciences; anticipated milestones of Ovid Therapeutics for the second half of this year; European Commission's approval of Akcea's TEGSEDI; Achieve Life Sciences' progress with Cytisine as an aid to smoking cessation and a regulatory event to watch out for today.
from RTT - Biotech https://ift.tt/2upE6eU
via IFTTT
No comments:
Post a Comment